Ayad Kareem Khan

Prof. Dr. Ayad Kareem Khan

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
JSJumat Salimon
Jumat Salimon
NSNadia Salih
Nadia Salih
EYEmad Yousif
Emad Yousif
AHAyad Hameed
Ayad Hameed
Ayad Kareem KhanAyad Kareem Khan
Ayad Kareem Khan
In the present study a new acridone derivatives were synthesized. The newly synthesized compounds were characterized by IR, NMR and C, H, N, S analyses. All newly synthesized compounds were screened for their antibacterial (Staphylococcus aureus, Streptococcus viridans and Escherichia coil) and antifungal (Gibberela, Cercospora arachidicola, Physolospora piricola and Fusarium oxysporum) studies. The results revealed that all synthesized compounds have a significant biological activity against the tested microorganisms

28 July 2023 in Journal of Advanced Pharmaceutical Technology & Research
Verified
Journal Article
Open access
FAFarah Haidar Abdulredha
Farah Haidar Abdulredha
MMMonther Faisal Mahdi
Monther Faisal Mahdi
Ayad Kareem KhanAyad Kareem Khan
Ayad Kareem Khan
A series of eight novels’ 1,3-diazetidin-2-ones have been proposed to assess their potential activities. They are intended to examine antiproliferative effects through inhibition of epidermal growth factor receptor (EGFR) expression. These eight compounds strongly interact with the EGFR protein, responsible for the activity. As part of a present study, these compounds were docked to the crystal structure of the EGFR (Protein Data Bank code: 1 M17) to determine their binding affinity at the active site. Based on computer predictions, two compounds were demonstrated high scores of 80.80 and 85.89. After analyzing ADME properties, these compounds were found to have significant potential for binding. Consequently, the abilities of gefitinib, erlotinib, imatinib, and sorafenib were selected for comparison as controls. Computational methods were performed to predict the critical disposition of eight novels’ 1,3-diazetidin-2-one derivatives to the EGFR. Moreover, a docking technique employing the Genetic Optimization for Ligand Docking program was conducted. Compounds 2 and 7 demonstrate a high docking peace-wise scoring function (PLP) fitness of 85.89 and 80.80, respectively. They fulfilled the Lipinski’s rule, topological descriptors, and fingerprints of drug-like molecular structure keys. These compounds can be used as lead compounds to develop novel antiproliferative agents. The outcome of applying this study is novel series of 1,3-diazetidin-2-one compounds as new analogs were designed and evaluated for their antiproliferative activity with a higher potency profile and binding affinity within the active sites of EGFR.

19 April 2022 in Al Mustansiriyah Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
YMYasir F. Muhsin
Yasir F. Muhsin
SAShakir M. Alwan
Shakir M. Alwan
Ayad Kareem KhanAyad Kareem Khan
Ayad Kareem Khan
Infections caused by bacteria have a significant impact on public health. Chemical synthesis of new derivatives of cephalexin inked to amino acid (tryptophan or histidine) through an amide bond at the acyl side chain is achieved. This is a new approach of incorporating, tryptophan and histidine into the the primary amino group of cephalexin, in order to provide a bulky group very close to the β-lactam ring. This chemical addition act as isosteric group to the alkoximino that protect beta lactam ring from bacterial beta lactamase enzyme. The new derivatives may show resistance to β-lactamases, improve activity and pharmacokinetic properties and may give new life for old drugs that are susceptible to hydrolysis by most β-lactamases. The chemical structures of these derivatives were confirmed by: FTIR, 1H-NMR spectroscopy, elemental micro analysis and some physical properties. Molecular docking on serine beta lactamase and prediction of ADME parameters were recorded using GOLD suite and Swiss ADME software respectively. Docking scores of the new derivatives of Cephalexin on β-lactamases were higher than those of Cephalexin, which may indicate better activity

14 January 2024 in Al Mustansiriyah Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
FHFarah Haidar
Farah Haidar
MMMonther Faisal Mahdi
Monther Faisal Mahdi
Ayad Kareem KhanAyad Kareem Khan
Ayad Kareem Khan
A series of novel 1,3-diazetidin-2-one derivatives were designed, synthesized, and evaluated preliminary (In Vitro) for their cytotoxic activity against the lung (A549) cancer cell line. GOLD software (version 2021.2.0) was used to conduct a molecular docking study; the tested derivatives demonstrated significant anticancer activity compared to the reference drug (erlotinib). PLP-fitness values for the final compounds are 79.81, 80.80, and 81.57, respectively, whereas the reference ligand, erlotinib, had a value of 76.20. The synthesized compounds were identified and characterized using physicochemical parameters (melting points and Rf values), FTIR, 1H-NMR, and 13C-NMR spectroscopy. According to the IC50 values for the synthesized derivatives, compounds N4a and N4b exhibit outstanding anti-proliferative activity with IC50 value of (7.51, 7.68) µM against A549 cell line, compared to erlotinib, which has an IC50 value of (11.5) µM.

1 August 2021 in Egyptian Journal of Chemistry
Verified
Journal Article
Closed access
AWAmmar Kadhim Wabdan
Ammar Kadhim Wabdan
MMMonther Faisal Mahdi
Monther Faisal Mahdi
Ayad Kareem KhanAyad Kareem Khan
Ayad Kareem Khan
Cancer is a significant worldwide public health issue. The adverse effects of anticancer chemotherapies still compromise the quality of life of patients. To identify new potential targeted anticancer agents, a series of pyrazoline derivatives were synthesized and evaluated for anticancer effects on A549 (human lung adenocarcenoma cell line). In silico evaluation methods were done before synthesis through molecular docking via genetic optimization for ligand docking (GOLD) Suite software with EGFR tyrosine kinase and exhibited significant tyrosine kinase inhibition activities compared with Erlotinb as a reference drug due to their hydrogen bonding and short contact interaction with key amino acids and these results are compatible with the experimental findings. The new derivatives were synthesized by incorporating pyrazoline pharmacophore into nabumetone moiety as a starting molecule and the chalcone derivatives as intermediate products. The compounds structure were confirmed by H-1-NMR, some physicochemical properties and infrared spectroscopy. An in vitro assay demonstrated that the final compounds (P1, P2, P3 and P4) exerted potent to moderate cytotoxic activity in the micromolar range with an IC50 values (15.409 mu M, 7.24 mu M, 27.05 mu M, 22.45 mu M) respectively when compared with Erlotinib (IC 50 =25.23 mu M) while (P5&P6) show weak activity. Pharmacokinetic and physicochemical properties of the final compounds predicted by using ADME evaluations. The results showed all the synthesized compounds have high oral bioavailability and good GI absorption.

9 July 2024 in Al Mustansiriyah Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
ZAZaid Alsalamy
Zaid Alsalamy
Ayad Kareem KhanAyad Kareem Khan
Ayad Kareem Khan
MHMohammed Dheyaa Hamdi
Mohammed Dheyaa Hamdi
AMAtheer Awad Mehde
Atheer Awad Mehde
Molecular docking simulation and synthesis of five compounds of N2, N4-bis (2-(4-substituted phenyl)-4-oxothiazolidin-3-yl)-3,5-dimethyl-1H-pyrrole-2,4-dicarboxamide was carried out to evaluate their theoretical binding affinities, targeting acute myeloid leukemia (AML). The chemical structure of the molecules was accurately drawn using ChemDraw Professional 19.1 software. The designed compounds were evaluated for their selectivity towards FLT3's ATP pocket (PDB ID:6JQR) in comparison with the reference ligand (Gilteritinib) by using GOLD suite from the Cambridge Crystallographic Data Centre (CCDC) software (Version 2021.2.0). All the designed compounds exhibited good binding energies with the receptor active pocket and had promising activity. Compounds 2E and 3E showed the highest PLP Fitness (83.30, 80.86 respectively) and it is higher than that of Gilteritinib (71.91). In-silico ADME and drug-likeness studies were performed by using the Swiss ADME server. The results showed that most of the designed compounds expected to be absorbed from the GIT. Compounds 2B-E have high expected GI absorption. All the investigated compounds have no predicted BBB penetration. Additionally, compounds 2A, 2C, 2D, and 3A are not a substrate to P-gps which may indicate a lower expected incidence of resistance by cancer cells in vitro studies. Finally, all of the investigated compounds are not considered to inhibit CYP1A2 enzyme, except for compounds 2A and 3D.